Table of contents


In this issue

p79 | doi:10.1038/nrc997

Top

Research Highlights

Apoptosis: Cheating death

p81 | doi:10.1038/nrc1009

Therapeutics: Mass destruction

p82 | doi:10.1038/nrc1004

Prognosis: Prediction power

p82 | doi:10.1038/nrc1006

Carcinogenesis: Double whammy

p83 | doi:10.1038/nrc1000

In the news

Out-of-body experience

p84 | doi:10.1038/nrc1002

Telomere maintenance: The road less travelled

p84 | doi:10.1038/nrc1008

Tumour suppressors: A greater loss

p85 | doi:10.1038/nrc1005

Epigenetics: Breaking the silence

p86 | doi:10.1038/nrc1001

Epigenetics: Gender-dependent tumour suppression

p86 | doi:10.1038/nrc1007

News in Brief

Technology | Oncogenes | Therapeutics | Chemoprevention

p87 | doi:10.1038/nrc1003

Tumorigenesis: Translating cancer

p87 | doi:10.1038/nrc999

Top

Reviews

Disruption of differentiation in human cancer: AML shows the way

Daniel G. Tenen

p89 | doi:10.1038/nrc989

Inhibiting the p53–MDM2 interaction: an important target for cancer therapy

Patrick Chène

p102 | doi:10.1038/nrc991

The endothelin axis: emerging role in cancer

Joel Nelson, Anna Bagnato, Bruno Battistini & Perry Nisen

p110 | doi:10.1038/nrc990

The role of p53 in determining sensitivity to radiotherapy

Andrei V. Gudkov & Elena A. Komarova

p117 | doi:10.1038/nrc992

Coordinated regulation of life and death by RB

B. Nelson Chau & Jean Y.J. Wang

p130 | doi:10.1038/nrc993

Top

Perspective

Opinion

An analysis of cancer research funding in the UK

Liam O'Toole, Paul Nurse & George Radda

p139 | doi:10.1038/nrc994

Natureview: Reviews and comment from the nature publishing group

p144 | doi:10.1038/nrc996

Extra navigation

Subscribe

Subscribe to Nature Reviews Cancer

naturejobs

natureproducts


Advertisement